Lead Optimization
Iterative improvement of candidate molecules for potency, selectivity, exposure, safety, and manufacturability before clinical development.
Core metadata
- ID: lead_optimization
- Era: Modern
- First known date: 1980 (decade)
- Region: Global pharmaceutical research laboratories
- Review status: source_checked
- Maturity: established
Prerequisites
- High-Throughput Screening (high_throughput_screening)
- Medicinal Chemistry (medicinal_chemistry)
- Pharmacokinetics and Pharmacodynamics (pharmacokinetics_pharmacodynamics)
Dependents
- None.
Fields
Field lanes
- Pharmaceuticals & Drug Development: Small-Molecule Drugs
Node sources
- Pharmaceutical Industry: Drug Discovery and Development (Encyclopaedia Britannica, 2026, textbook) • Supports: node, maturity
- Computational approaches streamlining drug discovery (Nature, 2023, review) • Supports: node, maturity
Prerequisite edge evidence
Edge/source evidence summary:
- Prerequisite edges: 3
- Average edge confidence: 68%
- Prerequisite sources: 3
- expert_inference: 3
| Prerequisite | Type | Confidence | Evidence level | Note | Sources |
|---|---|---|---|---|---|
| Medicinal Chemistry (medicinal_chemistry) | enabling | 68% | expert_inference | Medicinal Chemistry provides a capability that enables this technology without being the only possible path. |
|
| High-Throughput Screening (high_throughput_screening) | enabling | 68% | expert_inference | High-Throughput Screening provides a capability that enables this technology without being the only possible path. |
|
| Pharmacokinetics and Pharmacodynamics (pharmacokinetics_pharmacodynamics) | enabling | 68% | expert_inference | Pharmacokinetics and Pharmacodynamics provides a capability that enables this technology without being the only possible path. |
|
This page is generated from canonical era JSON and is indexable by URL.